Akoya Biosciences Inc 's (AKYA) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Akoya Biosciences Inc   (NASDAQ: AKYA)
 



  Akoya Biosciences Inc Outlook

On March 4 2024 the Akoya Biosciences Inc provided following guidance

Akoya Biosciences Inc. has reported record revenue in the fourth quarter of 2023, with $26.5 million in revenue for the quarter and a total revenue of $96.6 million for the full year of 2023. Looking ahead to 2024, the company is providing a financial outlook with a projected revenue range of $114.0-118.0 million for the full year. Additionally, Akoya Biosciences Inc. aims to achieve operating cash flow breakeven by the end of 2024. This positive growth trajectory demonstrates the company's continued success and strategic financial planning for the upcoming year.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.